Cargando…
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
Pharmacogenomics (PGx) is the study of genetic influences on an individual’s response to medications. Improvements in the quality and quantity of PGx research over the past two decades have enabled the establishment of commercial markets for PGx tests. Nevertheless, PGx testing has yet to be adopted...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492820/ https://www.ncbi.nlm.nih.gov/pubmed/34615849 http://dx.doi.org/10.1038/s41398-021-01600-7 |